The United States Food and Drug Administration inspected a Formulation facility in Sangareddy District, resulting in OAI status.
2 reports, 2 independent
Updated Jun 15
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The United States Food and Drug Administration inspected a Formulation facility in Sangareddy District, resulting in OAI status.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA acknowledged shortcomings in Glas data during the inspection process.1 source
FDA inspection of Formulation facility in Sangareddy District leads to OAI status.1 source
Keep exploring
The entities involved
-
Formulation
business
Nothing else this week.
-
United States Food and Drug Administration
agency of the US Department of Health and Human Services